Chesley Taft & Associates LLC Pfizer Inc Transaction History

Chesley Taft & Associates LLC

$2.13 Billion
Q4 2024

A detailed history of Chesley Taft & Associates LLC transactions in Pfizer Inc stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 152,440 shares of PFE stock, worth $4.04 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

152,440

Previous 148,607 2.58%

Holding current value

$4.04 Million

Previous $4.3 Million 5.95%

% of portfolio

0.19%

Previous 0.21%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	BUY	$24.8 - $30.19 $95,058 - $115,718	3,833 Added 2.58%	152,440 $4.04 Million
Q3 2024 Oct 07, 2024	SELL	$27.7 - $31.39 $60,275 - $68,304	-2,176 Reduced 1.44%	148,607 $4.3 Million
Q2 2024 Jul 19, 2024	SELL	$25.26 - $29.6 $11,190 - $13,112	-443 Reduced 0.29%	150,783 $4.22 Million
Q1 2024 Apr 15, 2024	SELL	$25.89 - $29.73 $109,385 - $125,609	-4,225 Reduced 2.72%	151,226 $4.2 Million
Q4 2023 Jan 11, 2024	BUY	$26.13 - $33.94 $13,561 - $17,614	519 Added 0.33%	155,451 $4.48 Million
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $730,946 - $854,402	-22,778 Reduced 12.82%	154,932 $5.14 Million
Q2 2023 Jul 17, 2023	SELL	$36.12 - $41.79 $110,888 - $128,295	-3,070 Reduced 1.7%	177,710 $6.52 Million
Q1 2023 Apr 11, 2023	SELL	$39.39 - $51.28 $106,786 - $139,020	-2,711 Reduced 1.48%	180,780 $7.38 Million
Q4 2022 Jan 19, 2023	SELL	$41.75 - $54.5 $15,197 - $19,838	-364 Reduced 0.2%	183,491 $0
Q3 2022 Oct 13, 2022	SELL	$43.76 - $53.42 $111,325 - $135,900	-2,544 Reduced 1.36%	183,855 $8.05 Million
Q2 2022 Jul 07, 2022	SELL	$46.53 - $55.17 $7,305 - $8,661	-157 Reduced 0.08%	186,399 $9.77 Million
Q1 2022 Apr 14, 2022	BUY	$45.75 - $56.69 $53,161 - $65,873	1,162 Added 0.63%	186,556 $9.91 Million
Q4 2021 Jan 05, 2022	BUY	$41.32 - $61.25 $102,804 - $152,390	2,488 Added 1.36%	185,394 $10.9 Million
Q3 2021 Oct 05, 2021	BUY	$39.25 - $50.42 $98,517 - $126,554	2,510 Added 1.39%	182,906 $7.87 Million
Q2 2021 Jul 07, 2021	BUY	$35.91 - $40.68 $50,992 - $57,765	1,420 Added 0.79%	180,396 $7.06 Million
Q1 2021 Apr 06, 2021	BUY	$33.49 - $37.77 $125,520 - $141,561	3,748 Added 2.14%	178,976 $6.49 Million
Q4 2020 Jan 11, 2021	SELL	$33.47 - $42.56 $16,567 - $21,067	-495 Reduced 0.28%	175,228 $6.45 Million
Q3 2020 Oct 08, 2020	SELL	$31.75 - $37.25 $86,391 - $101,357	-2,721 Reduced 1.52%	175,723 $6.45 Million
Q2 2020 Jul 08, 2020	SELL	$30.12 - $36.54 $54,366 - $65,954	-1,805 Reduced 1.0%	178,444 $5.84 Million
Q1 2020 Apr 15, 2020	SELL	$27.03 - $38.62 $48,789 - $69,709	-1,805 Reduced 0.99%	180,249 $5.88 Million
Q4 2019 Jan 10, 2020	SELL	$32.92 - $37.36 $20,344 - $23,088	-618 Reduced 0.34%	182,054 $7.13 Million
Q3 2019 Oct 07, 2019	SELL	$32.49 - $42.13 $81,712 - $105,956	-2,515 Reduced 1.36%	182,672 $6.56 Million
Q2 2019 Jul 10, 2019	SELL	$36.98 - $41.52 $962,182 - $1.08 Million	-26,019 Reduced 12.32%	185,187 $8.02 Million
Q1 2019 Apr 05, 2019	SELL	$37.5 - $41.2 $160,837 - $176,706	-4,289 Reduced 1.99%	211,206 $8.97 Million
Q4 2018 Jan 07, 2019	SELL	$38.47 - $43.86 $236,475 - $269,607	-6,147 Reduced 2.77%	215,495 $9.41 Million
Q3 2018 Oct 12, 2018	SELL	$34.47 - $41.81 $1,378 - $1,672	-40 Reduced 0.02%	221,642 $9.77 Million
Q2 2018 Jul 12, 2018	BUY	$32.98 - $35.16 $47,227 - $50,349	1,432 Added 0.65%	221,682 $8.04 Million
Q1 2018 Apr 11, 2018	SELL	$31.91 - $37.02 $23,581 - $27,357	-739 Reduced 0.33%	220,250 $7.82 Million
Q4 2017 Jan 10, 2018	SELL	$33.26 - $35.29 $151,333 - $160,569	-4,550 Reduced 2.02%	220,989 $8 Million
Q3 2017 Oct 13, 2017	BUY	$31.0 - $34.15 $6.99 Million - $7.7 Million	225,539	225,539 $8.05 Million

Others Institutions Holding PFE

# of Institutions

3,228

Shares Held

3.62B

Call Options Held

77.1M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesley Taft & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesley Taft & Associates LLC with notifications on news.

Account

Chesley Taft & Associates LLC Pfizer Inc Transaction History